Cargando…
Long Non-coding RNA DLEU2L Targets miR-210-3p to Suppress Gemcitabine Resistance in Pancreatic Cancer Cells via BRCA2 Regulation
Gemcitabine (GEM) resistance remains a challenging clinical issue to overcome in chemotherapy against pancreatic cancer. We previously demonstrated that miR-210 derived from pancreatic cancer stem cells enhanced the GEM-resistant properties of pancreatic cancer cells, thus identifying miR-210 as an...
Autores principales: | Xu, Fei, Wu, Heshui, Xiong, Jiongxin, Peng, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100451/ https://www.ncbi.nlm.nih.gov/pubmed/33968986 http://dx.doi.org/10.3389/fmolb.2021.645365 |
Ejemplares similares
-
BRCA1 and BRCA2 Variation in Taiwanese General Population and the Cancer Cohort
por: Chian, Jiasheng, et al.
Publicado: (2021) -
Everolimus regulates the activity of gemcitabine-resistant pancreatic cancer cells by targeting the Warburg effect via PI3K/AKT/mTOR signaling
por: Cui, Jing, et al.
Publicado: (2021) -
miR-15a-3p Protects Against Isoniazid-Induced Liver Injury via Suppressing N-Acetyltransferase 2 Expression
por: Li, Xinmei, et al.
Publicado: (2021) -
Long Non-Coding RNA MEG8 Suppresses Hypoxia-Induced Excessive Proliferation, Migration and Inflammation of Vascular Smooth Muscle Cells by Regulation of the miR-195-5p/RECK Axis
por: Xu, Dexing, et al.
Publicado: (2021) -
Long Non-Coding RNAs in Epithelial-Mesenchymal Transition of Pancreatic Cancer
por: Takahashi, Kenji, et al.
Publicado: (2021)